Pharma department tells companies to step up manufacture of anti-HIV drugs

At a meeting held with the manufacturers on Wednesday, a committee of experts constituted by the Department of Pharmaceuticals (DoP) asked companies such as Cipla, Mylan, Aurobindo and Hetero, among others, to evaluate supply chain and keep enough stock ready for India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2IJjMwo
via IFTTT